How to Govern AI Denials Appeals Agents for Providers

AI Denials Appeals Agents Are Agentic Workloads, Not Scripts

An AI denials appeals agent reviews a denied claim, retrieves supporting clinical documentation, determines an appeal strategy, and in many implementations drafts or submits the appeal to a payer with limited human review. This places the agent in the same category as other autonomous enterprise AI agents: it makes sequential decisions, calls multiple systems, and produces output that triggers downstream action. NIST's AI Risk Management Framework addresses this category of system under its Govern function, which calls for organizations to establish policies, roles, and accountability structures before deployment, not after an incident. Applying that principle here means defining, in writing, who owns the agent's access scope, who can approve a change to its permissions, and who is accountable if it submits an incorrect appeal. Treating the agent as an RPA script or a reporting tool understates the risk and typically results in access grants that are broader than the workflow requires.

Data Access Across EHR, Clearinghouse, and Payer Systems

A denials appeals agent typically needs access to the EHR for clinical documentation, the claims clearinghouse for claim status and remittance data, and one or more payer portals for submission and correspondence. Each of these systems holds electronic protected health information, and the HIPAA Security Rule's minimum-necessary standard applies to this access regardless of whether a human or an automated agent is making the request. In practice, many organizations provision agents with standing, broad credentials to these systems because it is operationally simpler than scoping access per task. OWASP's Top 10 for LLM Applications names this pattern Excessive Agency, where an agent is granted more functionality or data access than a given task requires. For a denials workflow, excessive agency looks like an agent that retains read access to a patient's full chart after resolving a single claim, or write access to a payer portal it does not need for a given case type.

Auditability: Building a Defensible Record

The HIPAA Security Rule also requires audit controls that record and examine activity in systems containing electronic PHI. For a denials appeals agent, this means every data access, every tool call, and every generated output should be logged and correlated to a specific denial case identifier, not aggregated into a general system log that cannot be traced back to an individual decision. This level of detail matters most when an appeal is later challenged: a provider organization needs to reconstruct exactly what documentation the agent accessed, what justification it generated, and who reviewed or approved the submission. Audit log retention should be aligned with both HIPAA requirements and applicable payer appeal timelines, which can extend well beyond a single claim cycle. Where possible, agent activity logs should feed into existing HIPAA-mandated audit systems rather than a separate, disconnected logging pipeline, since a fragmented audit trail is harder to produce and defend during a payer dispute or regulatory inquiry.

Validating Agent Output Before Submission

A second, distinct risk sits at the point where the agent's output becomes an action: submitting a clinical justification or an appeal letter to a payer. OWASP's LLM risk taxonomy describes this as Insecure Output Handling, where a downstream system acts on unvalidated model-generated content. In a denials workflow, this risk is concrete: an agent that misreads a clinical note or misapplies a payer's medical necessity criteria can generate an appeal that misstates the patient's condition or the basis for coverage. Provider organizations should define human-in-the-loop checkpoints for high-risk actions, specifically final appeal submission and clinical justification language, before granting the agent authority to act autonomously in production. These checkpoints should be tested against malformed or unexpected agent outputs prior to go-live, using known LLM risk categories as a baseline for what to test.